DETECT Fentanyl and Xylazine Act of 2024
Latest Action
Placed on Senate Legislative Calendar under General Orders. Calendar No. 654.
Official Summary
Official summary has not been imported yet.
GovScope Watchdog™
AI Government Intelligence™The DETECT Fentanyl and Xylazine Act of 2024 is a Senate bill introduced in the 118th Congress aimed at addressing issues related to fentanyl and xylazine. The bill was placed on the Senate Legislative Calendar under General Orders but ultimately failed or expired without further legislative action. There is no official summary or full text available, limiting detailed analysis of its provisions. The bill falls under the policy area of Science, Technology, and Communications, suggesting a focus on technological or scientific approaches to detect or manage these substances.
This bill sought to address fentanyl and xylazine detection through legislative means but did not advance beyond being scheduled on the Senate calendar and subsequently expired.
- The bill is titled DETECT Fentanyl and Xylazine Act of 2024 and was introduced in the Senate during the 118th Congress.
- No official summary or full text is publicly available, restricting detailed content analysis.
- The bill was placed on the Senate Legislative Calendar but did not progress to passage and is now classified as failed or expired.
['Potential beneficiaries could include federal agencies involved in drug enforcement or public health, scientific and technological organizations working on substance detection, and communities affected by fentanyl and xylazine misuse.']
['Lack of publicly available bill text and summary limits understanding of implementation requirements and costs.', 'Unclear authority or enforcement mechanisms due to missing detailed provisions.', 'Potential policy tradeoffs or oversight challenges cannot be assessed without full legislative language.']
The bill was introduced in the Senate and placed on the legislative calendar but did not advance to further consideration or passage. It is categorized under Science, Technology, and Communications, indicating a legislative interest in addressing drug detection through technological means during the 118th Congress. The failure or expiration status indicates it did not receive sufficient legislative support or priority to become law.
Hidden impact flags detected: 1
GovScope reviewed 1 policy-risk categories. Hover for a quick definition. Click detected flags for bill-specific details.
['If enacted, the bill could have led to increased federal investment in detection technologies for fentanyl and xylazine, potentially impacting law enforcement and public health strategies.', 'The focus on detection may have influenced research priorities or funding allocations in related scientific fields.']
The absence of an official summary and full bill text presents a significant transparency gap, hindering comprehensive public and expert review. This limits the ability to evaluate the bill's scope, funding, enforcement mechanisms, and potential impacts. Monitoring such gaps is important for ensuring informed legislative processes and accountability.
GovScope Intelligence Roadmap
Future bill intelligence will connect sponsors, committee referrals, related votes, campaign finance, disclosures, and stock trades into one legislative intelligence view.